Gold futures finished higher on Thursday as the risk aversion amid continued surge in Covid-19 infections and concerns over economic slowdown whetted safe haven bullion investments. However, the gains remained capped as investors awaited Moderna Inc's data on its experimental COVID-19 vaccine, which it is preparing to submit to an independent safety board to help determine its efficacy.
Gold futures for December delivery rose by $11.70 or 0.60% to settle at $1873.30 an ounce on the Comex division of the New York Mercantile. Spot gold up 0.1% to $1,865.96 per ounce.